M7824 in Subjects With HPV Associated Malignancies
NCT03427411
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
57
Enrollment
NIH
Sponsor class
Conditions
Human Papilloma Virus
Cervical Cancer
Oropharyngeal Cancer
Anal Cancer
Vaginal or Penile Cancer
Interventions
DRUG:
M7824
Sponsor
National Cancer Institute (NCI)